Study on the safety and rebound effect of SAT-001 for myopia in children
Official title: A Multi-center, Open-label, Controlled Extension Study to Evaluate the Rebound Effect and Long-term Safety of Software SAT-001 for the Inhibition of Myopia Progression and Treatment in Pediatric Patients With Myopia
Run by S-Alpha Therapeutics, Inc. · NCT06742268 · Data updated 2026-11-12
This study is testing if a new software treatment for myopia can safely help children aged 5 to under 9 years old without causing problems once they stop using it.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 8 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | S-Alpha Therapeutics, Inc. Industry-sponsored |
| Locations | 5 sites (Seoul, Choose One... and 4 other locations) |
| Status | Recruiting |
| Started | December 16, 2024 |
| Main results expected | October 30, 2025 |
| Study ends | July 30, 2026 |
| Registry record updated | January 9, 2025 |
| Trial ID | NCT06742268 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 5 to less than 9 years who completed the previous SAT-001 trial and have legal guardians willing to provide informed consent.
✕Probably not a fit
Patients who had less than 70% compliance in the previous trial will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather data on the long-term safety and rebound effect of SAT-001, a Software as a Medical Device (SaMD) designed to inhibit myopia progression in children. It follows participants aged 5 to less than 9 years who completed a previous trial, assessing changes in their refractive error over a 6-month period. The study will include both treatment and control groups, with participants continuing to wear spectacles during the extension phase. The primary focus is on understanding the rebound effect that may occur after treatment cessation.
Why it matters
Potential benefit: If successful, this study could provide insights into safer and more effective treatment strategies for managing myopia in children.
How similar studies have gone: Previous studies on myopia treatments have shown varying results, but the specific focus on the rebound effect in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants who have completed the previous clinical trial (SAT001-KP-002), and their legal guardians who agree to participate in this extension study and are willing to provide the signed informed consent after receiving and comprehending the explanation of the description of this clinical trial (subject under 6 can make a mark for agreement after full information and understanding) Exclusion Criteria: * Participants in the study group of the previous clinical trial (SAT001-KP-002) with a compliance rate of less than 70% (overall compliance throughout the study period). * Other reasons for participation in the trial at the discretion of the investigator
Where it's running
-
Kangbuk Samsung Hospital
Seoul, Choose One..., South Korea Recruiting -
Hallym University Dongtan Sacred heart Hospital
Hwaseong-si, Gyeonggi-do, South Korea Recruiting -
Gachon University Gil Medical Center
Incheon, South Korea Recruiting -
Seoul Asan Medical Center
Seoul, Choose One..., South Korea Not yet recruiting -
Chung-Ang University Gwang Myeong Hospital
Gwangmyeong, South Korea Not yet recruiting
Study contacts
- Principal investigator: Paik, MD — Gachon University Gil Medical Center
- Study coordinator: Jihye Lee, MSc
- Email: sophie@salphadtx.com
- Phone: (+82) 2-3487-3923
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.